Belgium· BE-AMP-SAM660468-00
Upstaza 2.8 10*11 vg/0.5 ml
A eladocagene exuparvovec product containing eladocagene exuparvovec, registered in Belgium by PTC Therapeutics International. The same ATC class is registered in 10 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Eladocagene exuparvovec is registered in 10 of 19 countries.
Countries holding a registration under ATC A16AB26 (eladocagene exuparvovec), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Eladocagene exuparvovec · ATC A16AB26
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Eladocagene Exuparvovec
- Manufacturer
- PTC Therapeutics International
- Country
- Belgium (BE)
- ATC code
- A16AB26
- ATC class
- Eladocagene exuparvovec
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb4751780
- be_apb7738784
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Eladocagene exuparvovec in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesKEBILIDIPTC Therapeutics, Inc.
- SpainUPSTAZA 2,8 × 10E11 GENOMAS VECTORIALES (VG)/0,5 ML PARA SOLUCION PARA PERFUSIONPtc Therapeutics International Limited
- FinlandUpstazaPTC Therapeutics International limited
- FranceUPSTAZA 2,8 x 100 000 000 000 génomes de vecteur (vg)/0,5 mL, solution pour perfusionPTC THERAPEUTICS INTERNATIONAL (IRLANDE)
- United KingdomUpstaza 280 giga vector genomes/0.5ml solution for infusion vialsPTC Therapeutics Ltd
- CzechiaUPSTAZAPTC Therapeutics International Limited, Dublin 2
- IcelandUpstazaPTC Therapeutics International Limited*
- NetherlandsUpstaza 2,8 x 10^11 vg/0.5 ml, oplossing voor infusiePTC Therapeutics International Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Upstaza
- Liechtenstein · Upstaza
- Norway · Upstaza
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/27c7362c-4c47-44cd-a375-324dc21794c5 GET /v1/drugs/27c7362c-4c47-44cd-a375-324dc21794c5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for infusion",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Upstaza 2.8 10*11 vg/0.5 ml",
"name_fr": "Upstaza 2.8 10*11 vg/0.5 ml",
"name_nl": "Upstaza 2.8 10*11 vg/0.5 ml",
"amp_code": "SAM660468-00",
"strengths": [
"5.6000",
"5.6000"
],
"pack_count": 1,
"substances": [
"Eladocagene Exuparvovec",
"Disodium Hydrogen Phosphate",
"Potassium Chloride",
"Potassium Dihydrogen Phosphate",
"Sodium Chloride"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Eladocagene Exuparvovec",
"authorisation_numbers": [
"EU/1/22/1653/001"
]
}See everything about eladocagene exuparvovec.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.